IP Library Granted Patent US 8,535,913
Granted Patent B2
US 8,535,913 · App. 12/632,721 · Granted Sep 17, 2013

Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells

Inventors: Gail K. Naughton (San Diego, CA); Frank Ziegler (Encinitas, CA); Mark Baumgartner (San Diego, CA); Kyle Nickey (Vista, CA)
Assignee: Histogen, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,535,913
App. No.
12/632,721
Granted
Sep 17, 2013
Kind
B2
Abstract

The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Claims (23)

1. A method of producing a soluble composition for promoting hair growth in a human subject comprising:

culturing fibroblast cells under hypoxic conditions on a microcarrier bead or three dimensional surface in a suitable growth medium, under 1-5% oxygen for at least 2 weeks, thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete a soluble composition that promotes hair growth when administered to the hair follicles of a subject, resulting in increased hair growth; and

collecting the growth medium after said 2 weeks.

2. A method of producing a soluble composition for promoting hair growth in a human subject comprising:

culturing fibroblast cells under hypoxic conditions on a microcarrier bead or three dimensional surface in a suitable growth medium, under 1-5% oxygen for at least 2 weeks, wherein the cells produce and secrete a soluble composition that promotes hair growth when administered to the hair follicles of a subject, resulting in increased hair growth; and

collecting the growth medium after said two weeks.

3. The method of claim 1 or 2 , wherein the soluble composition produced is formulated for administration to a hair follicle.

4. The method of claim 3 , wherein the composition is further formulated for administration to a cell in vivo.

5. The method of claim 3 , wherein the further formulated for administration to a cell ex vivo.

6. The method of claim 3 , wherein the hair follicle is transplanted into a subject.

7. The method of claim 1 or 2 , wherein the surface comprises mesh.

8. The method of claim 1 or 2 , wherein the growth medium comprises serum.

9. The method of claim 1 or 2 , wherein the growth medium is serum-free.

10. The method of claim 1 or 2 , wherein the composition is suitable for intradermal or topical administration.

11. A method of promoting hair growth in a subject comprising:

administering directly to hair follicles of a human subject a composition produced by culturing fibroblast cells under hypoxic conditions on a microcarrier bead in a suitable growth medium, under 1-5% oxygen for at least 2 weeks, thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete a soluble composition that promotes hair growth when administered to the hair follicles of a subject, resulting in increased hair growth, and wherein the growth medium after said 2 weeks is collected to obtain the soluble composition containing increased levels of VEGF and KGF as compared with a composition from cells grown under normoxic conditions, thereby promoting hair growth in the subject.

12. A method of promoting hair growth in a subject comprising:

administering directly to hair follicles of a human subject a composition produced by culturing fibroblast cells under hypoxic conditions on a microcarrier bead in a suitable growth medium, under 1-5% oxygen for at least 2 weeks, wherein the cells produce and secrete a soluble composition that promotes hair growth when administered to the hair follicles of a subject, resulting in increased hair growth, and wherein the growth medium is collected after said two weeks to obtain the soluble composition containing increased levels of VEGF and KGF as compared with a composition from cells grown under normoxic conditions, whereby hair growth is promoted.

13. The method of claim 11 or 12 , wherein the contacting is by intradermal or topical administration.

14. The method of claim 11 or 12 , wherein the cultured cells are neonatal fibroblast cells.

15. The method of claim 1 or 11 , wherein the soluble composition comprises hair growth stimulating effective amounts of at least one or more of Wnt proteins, VEGF, FGF, KGF, follistatin and a combination thereof.

16. The method of claim 15 , wherein the Wnt proteins, VEGF, KGF, FGF and follistatin are upregulated as compared with soluble compositions produced in oxygen conditions of about 15-20% oxygen.

17. The method of claim 3 or 11 , wherein the composition is formulated for injectable administration.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2024
From: HISTOGEN INC.
To: ALLERGAN SALES, LLC
Reel/Frame 067559/0977 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2010
From: NAUGHTON, GAIL K.; ZIEGLER, FRANK; BAUMGARTNER, MARK; NICKEY, KYLE
To: HISTOGEN, INC.
Reel/Frame 025064/0166 →
Continuity (7)
Continuation In Part 12509171 · Jul 24, 2009
Continuation In Part 12501312 · Jul 10, 2009
Continuation In Part 12363488 · Jan 30, 2009
Provisional Application 61024854 · Jan 30, 2008
Provisional Application 61034361 · Mar 6, 2008
Provisional Application 61050940 · May 6, 2008
Related Publication 20100210530A1 · Aug 19, 2010